Betaferon News (4 articles)

Study results published in Neurology provide the longest follow-up data among patients with multiple sclerosis.Berlin, June 8, 2010 – Results from the 16-year follow-up to the pivotal Betaferon® (interferon-beta-1b) trial, published today in the journal Neurology, provide the longest and most...

Published on 8 June 2010, 04:41

Categories: AEs Betaferon Interferon-beta-1b MS Multiple Sclerosis Neurology

Berlin, December 1, 2009 – Bayer Schering Pharma AG announced today that the Chinese State Food and Drug Administration (SFDA) has approved Betaferon® (interferon beta-1b) therapy for patients with relapsing-remitting multiple sclerosis (MS). Bayer plans to launch Betaferon in China by mid...

Published on 1 December 2009, 04:53

Categories: Betaferon Betaseron China Drugs interferon beta-1b MS Multiple Sclerosis

New data presented at European Multiple Sclerosis Congress ECTRIMS:Düsseldorf, Germany, September 10, 2009 – The multiple sclerosis drug Betaferon® (interferon beta-1b) of Bayer Schering Pharma AG, Germany, may play a role in the protection of brain tissue in patients with multiple...

Published on 10 September 2009, 15:13

Categories: BECOME Study Betaferon Drugs interferon beta-1b MS Multiple Sclerosis Oxidative stress RRMS

Easy-to-use pack is designed to improve patient acceptance of therapy right from the start Berlin, March 27, 2009 – Bayer will launch a titration pack for patients with multiple sclerosis (MS) that is specially designed to make it easier for them to start Betaferon® (interferon...

Published on 28 March 2009, 06:03

Categories: Betaferon Betaseron Drugs MS Multiple Sclerosis Nervous system